top of page
>
>
What can portfolio management do for early commercialization?
Client Problems
- Commercial Heads need to develop specific disease area strategies and seek Governance approval
- Teams need guidance on governance-approved TA priorities (e.g., TPP hurdles; prioritized indications and/or MOAs, development plans, diagnostic strategies)
What We Did
- Provide strategic support and analytical horsepower to TA Heads and cross-functional disease area strategy teams
- Provide consistent support across TA’s and share best practices (e.g., TPP consistency; analytical tools; guidance for governance)
Our Results And Insight
- Framework for disease area strategy
- Consistent TPP approach, including market research
- Evaluate scenarios and analyze sensitivity to key assumptions
See other case studies
Portfolio Management case studies >
Service Areas Details
Portfolio Management (Early Commercialization)
Therapeutic Areas Details
N/A
Featured Consultants
bottom of page